<?xml version="1.0" ?>
<document id="71d134916c750fb6f875d3936a957b27a5df72bc">
  <chunk id="71d134916c750fb6f875d3936a957b27a5df72bc.c0" text="Debate around infection-dependent hemophagocytic syndrome in paediatrics">
    <entity charOffset="49-57" id="71d134916c750fb6f875d3936a957b27a5df72bc.c0.e0" ontology_id="DOID_225" text="syndrome" type="disease"/>
  </chunk>
  <chunk id="71d134916c750fb6f875d3936a957b27a5df72bc.c1" text="Background: Hemophagocytic syndrome (HPS) is clinically defined as a combination of fever, liver dysfunction, coagulation abnormalities, pancytopenia, progressive macrophage proliferation throughout the reticuloendothelial system, and cytokine over-production, and may be primary or secondary to infectious, auto-immune, and tumoral diseases. The most consistent association is with viral infections but, as it is still debated whether any micro-organisms are involved in its pathogenesis, we critically appraised the literature concerning HPS and its relationship with infections.">
    <entity charOffset="27-35" id="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e0" ontology_id="DOID_225" text="syndrome" type="disease"/>
    <entity charOffset="37-40" id="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e1" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <entity charOffset="540-543" id="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e2" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <pair e1="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e0" e2="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e1" id="71d134916c750fb6f875d3936a957b27a5df72bc.c1.p0" relation="true"/>
    <pair e1="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e0" e2="71d134916c750fb6f875d3936a957b27a5df72bc.c1.e2" id="71d134916c750fb6f875d3936a957b27a5df72bc.c1.p1" relation="true"/>
  </chunk>
  <chunk id="71d134916c750fb6f875d3936a957b27a5df72bc.c2" text="Discussion: Infection-dependent HPS has been widely observed, but there are no data concerning its incidence in children. A better understanding of the pathophysiology of HPS may clarify the interactions between the immune system and the variously implicated potential infectious agents. Epstein-Barr virus (EBV) infection has been prominently associated with HPS, with clonal proliferation and the hyperactivation of EBV-infected T cells. However, a number of other viral, bacterial, fungal, and parasitic infections have been reported in association with HPS. In the case of low-risk HPS, corticosteroids and/or intravenous immunoglobulin or cyclosporine A may be sufficient to control the biological process, but etoposide is recommended as a means of reversing infection-dependent lymphohistiocytic dysregulation in high-risk cases.">
    <entity charOffset="32-35" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e0" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <entity charOffset="171-174" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e1" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <entity charOffset="360-363" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e2" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <entity charOffset="557-560" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e3" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <entity charOffset="586-589" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e4" ontology_id="CHEBI_46711" text="HPS" type="chemical"/>
    <entity charOffset="591-606" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e5" ontology_id="CHEBI_50858" text="corticosteroids" type="chemical"/>
    <entity charOffset="644-656" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e6" ontology_id="CHEBI_4031" text="cyclosporine" type="chemical"/>
    <entity charOffset="716-725" id="71d134916c750fb6f875d3936a957b27a5df72bc.c2.e7" ontology_id="CHEBI_4911" text="etoposide" type="chemical"/>
  </chunk>
</document>
